Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 1998, p. 1425-1427, Vol. 36, No. 5
Instituto Nacional de Microbiología
"Dr. C. G. Malbrán,
Received 27 May 1997/Returned for modification 12 July
1997/Accepted 31 January 1998
Brucellosis in Argentina is currently investigated in bank donor
blood by the standard plate agglutination test (PAT). This study
evaluated the buffered plate antigen test (BPA), now used to screen for
bovine brucellosis, as a screen for human disease. Of 57 sera from
patients with culture-confirmed brucellosis, 100% were detected with
the BPA. Of 142 sera positive by rose bengal (RB) and complement
fixation (CF), from patients with clinical evidence of brucellosis, the
BPA detected 100%. Of 307 sera from a nonsymptomatic population that
were RB and CF negative, the BPA detected 99.67% of the negative sera.
The data indicate that the BPA is satisfactory compared to the other
agglutination tests employed. It is an inexpensive and practical
screening test and reduces the nonspecific reactions detected by the
PAT.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Buffered Plate Antigen Test as a Screening Test for
Diagnosis of Human Brucellosis
*
Corresponding author. Mailing address: Instituto
Nacional de Microbiología "Dr. C. G. Malbrán,"
Velez Sarsfield 563, 1281 Buenos Aires, Argentina. Phone:
54-1-303-1806/11. Fax: 54-1-303-2382. E-mail: NIDIA{at}IMPSAT1.COM.AR.
Journal of Clinical Microbiology, May 1998, p. 1425-1427, Vol. 36, No. 5
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»